Navigation Links
North American Nuclear Medicine / Radiopharmaceutical Market Worth $5.55 Billion by 2017
Date:4/10/2013

DALLAS, April 10, 2013 /PRNewswire/ --

The "North American Nuclear Medicine/Radiopharmaceuticals Market & Stable Isotopes [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Latin America, Europe, Asia, and Rest of the World.

Browse

  • 120  market data tables
  • 29  figures
  • 280  pages and an in-depth Table of Content on "North American Nuclear Medicine / Radiopharmaceutical Market"

http://www.marketsandmarkets.com/Market-Reports/north-american-nuclear-medicine-radiopharmaceuticals-market-1108.html

Early buyers will receive 10% customization on this report.

This report studies the North American nuclear medicine market over the forecast period 2012-2017.

The North American radiopharmaceutical market was valued at $1.9 billion in 2012 and is poised to reach $2.7 billion by 2017 at a CAGR of 7.2%. It is estimated that Tc-99m diagnostic procedures are expected to increase by more than 15% in mature markets such as North America, between 2010 and 2030, however shortage of Mo-99/Tc-99m has been a threat to this industry. The scheduled shutdown of the NRU reactor in 2016 is a major risk for manufacturers in the near future. Companies have increased the production of thallium to meet the shortage, as it is the most commonly used substitute for technetium-99 in cardiac-stress tests, conducted to evaluate the functioning of coronary arteries. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications.

Increasing use of SPECT and PET scans, technical advancements in equipment and other factors such as rising awareness of radiopharmaceuticals among physicians, alpha radio immunotherapy based targeted cancer treatment, and ready availability of north american nuclear medicine / radiopharmaceutical market from cyclotrons have driven the market. High cost of devices using radioisotopes, short half-life, lack of good manufacturing practices, and stringent regulatory approvals are major hurdles to growth of the market.

North America is the dominant market for diagnostic radioisotopes. The U.S. is the largest consumer market for radiopharmaceuticals, while Canada is one of the largest producers of Tc-99m.

Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Triad Isotopes, Inc. (U.S.), Cardinal Health dominated with more than 40% share in 2012.

The stable isotopes market was less than $50 million in 2012 and poised to grow at high double digit CAGR in the next 5 years. Carbon-13 commanded the largest share of the global stable isotope market in 2012; however deuterium and oxygen show tremendous potential to grow in the near future. The market was dominated by two players, Cambridge Isotope Laboratories (CIL) (U.S.) and Isotec (Sigma Aldrich) (U.S.) in 2012 jointly contributing more than 90% to the North America revenue.

Buy a copy of this report @http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=1108

Browse related reports to Pharmaceutical Market @http://www.marketsandmarkets.com/pharmaceutical-market-research-3.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets



'/>"/>
SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Honey Bee Beekeeping Class at North Island College’s Courtenay Campus
2. North American Injectable Drug Delivery Market worth $16.6 Billion by 2017
3. Northstar Biosciences Launches All Natural Skincare Solutions
4. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
5. New State-of-the-Art Rotor Balancing Facility Opened at Vibration Solutions North
6. Professor of Art from Northern Virginia Community College Lectures at Cajal Institute
7. Aviir Signs Distribution And Expansion Pact Covering 19 Middle Eastern And North African Countries
8. Aviir Signs Distribution and Expansion Pact Covering 19 Middle Eastern and North African Countries
9. Dallas-Fort Worth Fertility Associates Celebrates First Birth in North Texas from Advanced Trophectoderm Biopsy Screening Technology
10. Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry
11. BioSpace Spotlights Northwests Life Science Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... Brain Sentinel, Inc. has received US ... System, the Brain Sentinel® Seizure Monitoring and Alerting System. The adjunctive seizure monitoring ... of rest. A lightweight, non-invasive monitor is placed on the belly of the ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, ... partnership with Compass Research . GGI's mission is to advance global health and ... child in need in honor of each clinical trial volunteer. The vision of GGI ...
(Date:2/23/2017)... ... February 22, 2017 , ... ... have been named Fellows of the Society this year, the Fellows Committee has ... multidisciplinary fields of optics, photonics, and imaging as well as their service to ...
(Date:2/22/2017)... SAN DIEGO , Feb. 22, 2017  PrimeVax ... , will be presenting at the Annual Biocom Global ... on March 2, at 11:15 AM, at the Torrey ... are thankful to the organizers at Biocom who have ... this international symposium of biotechnology companies, investors, and clinical ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):